Index Ventures to unveil $578M European VC fund

Index Ventures is set to announce a new, $578 million European venture fund that will back a fresh slate of bets in the biotech field. And it's hired some top hands to run the fund: Dominique Vidal, the former CEO of Yahoo Europe, and Guido Magni, former global head of medical science at Roche. They plan to make about 15 investments averaging €25 million each, targeting companies with a revenue growth rate of 25 percent or more.

"We can provide pre-initial public offering financing, or funding for acquisitions to help companies achieve further growth," said Vidal, striking a tone that seemed to be geared more to technology than biotechnology.

- see this release
- read the report from the Financial Times

Suggested Articles

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.

More than half of the participants met the primary endpoint, teeing Sanofi up to file for FDA approval of the complement C1s inhibitor.

Cellarity is combining artificial intelligence, a protein discovery platform and what it calls “network biology” in a new drug discovery approach.